Suchergebnisse - "Weinreich, David M"

PubPharm (11)

1

Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection : A Randomized Clinical Trial

enthalten in: JAMA | 2022

von O'Brien, M. | Forleo-Neto, E. | Sarkar, N. | +136

UpdateOf: medRxiv. 2021 Sep 18;:. - PMID 34159343

2

Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma

enthalten in: The New England journal of medicine | 2021

von Bacharier, L. | Maspero, J. | Katelaris, C. | +123

CommentIn: N Engl J Med. 2021 Dec 9;385(24):2297-2298. - PMID 34879454

3

REGEN-COV Antibody Combination and Outcomes in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +138

4

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma

enthalten in: The New England journal of medicine | 2021

von Wechsler, M. | Ruddy, M. | Pavord, I. | +13

5

The monoclonal antibody combination REGEN-COV protects against SARS-CoV-2 mutational escape in preclinical and human studies

enthalten in: Cell | 2021

von Copin, R. | Baum, A. | Wloga, E. | +34

6

Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy : an open-label, multi-centre, single-arm, phase 2 trial

enthalten in: The Lancet. Oncology | 2021

von Stratigos, A. | Sekulic, A. | Peris, K. | +35

CommentIn: Nat Rev Clin Oncol. 2021 Jul;18(7):400. - PMID 34035503

7

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50% : a multicentre, open-label, global, phase 3, randomised, controlled trial

enthalten in: Lancet (London, England) | 2021

von Sezer, A. | Kilickap, S. | Gümüş, M. | +24

CommentIn: Lancet. 2021 Feb 13;397(10274):557-559. - PMID 33581807

8

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

enthalten in: The New England journal of medicine | 2021

von Weinreich, D. | Sivapalasingam, S. | Norton, T. | +131

CommentIn: N Engl J Med. 2021 Jan 21;384(3):289-291. - PMID 33471984

9

Evinacumab for Homozygous Familial Hypercholesterolemia

enthalten in: The New England journal of medicine | 2020

von Raal, F. | Rosenson, R. | Reeskamp, L. | +114

CommentIn: N Engl J Med. 2020 Aug 20;383(8):775-776. - PMID 32813955

10

Cemiplimab in locally advanced cutaneous squamous cell carcinoma : results from an open-label, phase 2, single-arm trial

enthalten in: The Lancet. Oncology | 2020

von Migden, M. | Khushalani, N. | Chang, A. | +19